Wenchen Gong

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0002-7637-3538

发表论文 66 篇 · 总被引 1039 次 · h-index 18

代表论文

• Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma (2025 · Cell Death and Disease · 被引 13)
• Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer (2025 · Frontiers in Immunology · 被引 11)
• CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma (2024 · Cancer Gene Therapy · 被引 9)
• 5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma (2025 · EMBO Molecular Medicine · 被引 7)
• Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial (2026 · Nature Communications · 被引 6)
• Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses (2025 · Leukemia · 被引 5)